Career Development Program in Omics of Lung Diseases (K12)

The summary for the Career Development Program in Omics of Lung Diseases (K12) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Career Development Program in Omics of Lung Diseases (K12): The long-term objectives of this program are to develop multidisciplinary career development programs that will equip new MD and PhD (or equivalent) investigators with the knowledge and skills to apply pan-omics and integrated approaches to elucidating genomic and molecular bases of lung disease, including heterogeneity, key regulatory networks, and relevant disease biomarkers, with the goal of advancing understanding of lung disease pathobiology and lung disease personalized medicine applications. The required expertise should include bioinformatics, experience in utilizing data from large cohorts and electronic medical records, techniques of integrative genomics and systems analysis, along with expertise, or at least familiarity, with clinical research and pulmonary medicine. Given the multidisciplinary nature of the research training, proposing multiple PD(s)/PI(s) is encouraged.
Federal Grant Title: Career Development Program in Omics of Lung Diseases (K12)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HL-13-023
Type of Funding: Grant
CFDA Numbers: 93.838
CFDA Descriptions: Lung Diseases Research
Current Application Deadline: Oct 26, 2012
Original Application Deadline: Oct 26, 2012
Posted Date: Jul 26, 2012
Creation Date: Jul 26, 2012
Archive Date: Nov 26, 2012
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordi...
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissu...
Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clin...
Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models
Lung Response to Inhaled Highly Toxic Chemicals
Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
More Grants from the National Institutes of Health
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com